Role of the T cell in the genesis of angiotensin II-induced hypertension and vascular dysfunction

Journal of Experimental Medicine

Volumn 204, Issue 10, 2007, Pages 2449-2460

  Guzik, Tomasz J ^a   Hoch, Nyssa E ^a   Brown, Kathryn A ^a   McCann, Louise A ^a   Rahman, Ayaz ^a   Dikalov, Sergey ^a   Goronzy, Jorg ^a   Weyand, Cornelia ^a   Harrison, David G ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CCR5; DEOXYCORTICOSTERONE ACETATE; ETANERCEPT; RANTES; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; ADOPTIVE TRANSFER; ADVENTITIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL ADHESION; CELL FUNCTION; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; HYPERTENSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; VASCULAR DISEASE;

ANGIOTENSIN II; ANIMALS; CELL MOVEMENT; HYPERTENSION; LYMPHOCYTE ACTIVATION; MICE; MICE, KNOCKOUT; NADPH OXIDASE; T-LYMPHOCYTES; VASCULAR DISEASES;

EID: 34948825774     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20070657     Document Type: Article

References (71)

1. Wang, Y., and Q.J. Wang. 2004. The prevalence of prehypertension and hypertension among US adults according to the new joint national committee guidelines: new challenges of the old problem. Arch. Intern. Med. 164:2126-2134.
2. Chobanian, A.V., G.L. Bakris, H.R. Black, W.C. Cushman, L.A. Green, J.L. Izzo Jr., D.W. Jones, B.J. Materson, S. Oparil, J.T. Wright Jr., and E.J. Roccella. 2003. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High blood pressure: the JNC 7 report. JAMA. 289:2560-2572.
3. Lewington, S., R. Clarke, N. Qizilbash, R. Peto, and R. Collins. 2002. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 360:1903-1913.
4. Naviar, G.L., M.C. Prieto-Carrasquero, and H. Kobori. 2006. Molecular Aspects of the renal renin-angiotensin system. In Molecular Mechanisms in Hypertension. R. Re, D. DiPette, E. Schiffrin, and R. Sowers J., editors. Taylor and Francis, London and New York. 3-14 pp.
5. Kim, S., and H. Iwao. 2000. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol. Rev. 52:11-34.
6. Yusuf, S., P. Sleight, J. Pogue, J. Bosch, R. Davies, and G. Dagenais. 2000. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N. Engl. J. Med. 342:145-153.
7. Huang, P.L., Z. Huang, H. Mashimo, K.D. Bloch, M.A. Moskowitz, J.A. Bevan, and M.C. Fishman. 1995. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature. 377:239-242.
8. Tang, K.M., G.R. Wang, P. Lu, R.H. Karas, M. Aronovitz, S.P. Heximer, K.M. Kaltenbronn, K.J. Blumer, D.P. Siderovski, Y. Zhu, and M.E. Mendelsohn. 2003. Regulator of G-protein signaling-2 mediates vascular smooth muscle relaxation and blood pressure. Nat. Med. 9:1506-1512.
9. Hoffman, W.E., M.I. Phillips, E. Wilson, and P.G. Schmid. 1977. A pressor response associated with drinking in rats. Proc. Soc. Exp. Biol. Med. 154:121-124.
10. Crowley, S.D., S.B. Gurley, M.J. Herrera, P. Ruiz, R. Griffiths, A.P. Kumar, H.S. Kim, O. Smithies, T.H. Le, and T.M. Coffman. 2006. Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney. Proc. Natl. Acad. Sci. USA. 103:17985-17990.
11. Lifton, R.P., A.G. Gharavi, and D.S. Geller. 2001. Molecular mechanisms of human hypertension. Cell. 104:545-556.
12. Lassegue, B., and R.E. Clempus. 2003. Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am. J. Physiol. Regul. Integr. Comp. Physiol. 285:R277-R297.
13. Landmesser, U., H. Cai, S. Dikalov, L. McCann, J. Hwang, H. Jo, S.M. Holland, and D.G. Harrison. 2002. Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II. Hypertension. 40:511-515.
14. Landmesser, U., S. Dikalov, S.R. Price, L. McCann, T. Fukai, S.M. Holland, W.E. Mitch, and D.G. Harrison. 2003. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J. Clin. Invest. 111:1201-1209.
15. Griendling, K.K., C.A. Minieri, J.D. Ollerenshaw, and R.W. Alexander. 1994. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ. Res. 74:1141-1148.
16. Gryglewski, R.J., R.M. Palmer, and S. Moncada. 1986. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature. 320:454-456.
17. Wilcox, C.S. 2005. Oxidative stress and nitric oxide deficiency in the kidney: a critical link to hypertension? Am. J. Physiol. Regul. Integr. Comp. Physiol. 289:R913-R935.
18. Zimmerman, M.C., E. Lazartigues, J.A. Lang, P. Sinnayah, I.M. Ahmad, D.R. Spitz, and R.L. Davisson. 2002. Superoxide mediates the actions of angiotensin II in the central nervous system. Circ. Res. 91:1038-1045.
19. Jackson, S.H., S. Devadas, J. Kwon, L.A. Pinto, and M.S. Williams. 2004. T cells express a phagocyte-type NADPH oxidase that is activated after T cell receptor stimulation. Nat. Immunol. 5:818-827.
20. Nataraj, C., M.I. Oliverio, R.B. Mannon, P.J. Mannon, L.P. Audoly, C.S. Amuchastegui, P. Ruiz, O. Smithies, and T.M. Coffman. 1999. Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway. J. Clin. Invest. 104:1693-1701.
21. Rodriguez-Iturbe, B., Y. Quiroz, M. Nava, L. Bonet, M. Chavez, J. Herrera-Acosta, R.J. Johnson, and H.A. Pons. 2002. Reduction of renal immune cell infiltration results in blood pressure control in genetically hypertensive rats. Am. J. Physiol. Renal Physiol. 282:F191-F201.
22. Bataillard, A., J.C. Freiche, M. Vincent, J. Sassard, and J.L. Touraine. 1986. Antihypertensive eff ect of neonatal thymectomy in the genetically hypertensive LH rat. Thymus. 8:321-330.
23. Balsari, A., R. Marolda, C. Gambacorti-Passerini, G. Sciorelli, G. Tona, E. Cosulich, D. Taramelli, G. Fossati, G. Parmiani, and N. Cascinelli. 1986. Systemic administration of autologous, alloactivated helper-enriched lymphocytes to patients with metastatic melanoma of the lung. A phase I study. Cancer Immunol. Immunother. 21:148-155.
24. Minagawa, M., J. Narita, T. Tada, S. Maruyama, T. Shimizu, M. Bannai, H. Oya, K. Hatakeyama, and T. Abo. 1999. Mechanisms underlying immunologic states during pregnancy: possible association of the sympathetic nervous system. Cell. Immunol. 196:1-13.
25. Muller, D.N., E. Shagdarsuren, J.K. Park, R. Dechend, E. Mervaala, F. Hampich, A. Fiebeler, X. Ju, P. Finckenberg, J. Theuer, et al. 2002. Immunosuppressive treatment protects against angiotensin II-induced renal damage. Am. J. Pathol. 161:1679-1693.
26. Herrera, J., A. Ferrebuz, E.G. Macgregor, and B. Rodriguez-Iturbe. 2006. Mycophenolate mofetil treatment improves hypertension in patients with psoriasis and rheumatoid arthritis. J. Am. Soc. Nephrol. 17:S218-S225.
27. Tian, N., J.W. Gu, S.J. Braddy, R.A. Rose, M.D. Hughson, and R.D. Manning Jr. 2007. Immune suppression prevents renal damage and dysfunction and reduces arterial pressure in salt-sensitive hypertension. Am. J. Physiol. Heart Circ. Physiol. 292:H1018-H1025.
28. Seaberg, E.C., A. Munoz, M. Lu, R. Detels, J.B. Margolick, S.A. Riddler, C.M. Williams, and J.P. Phair. 2005. Association between highly active antiretroviral therapy and hypertension in a large cohort of men followed from 1984 to 2003. AIDS. 19:953-960.
29. Morishita, R., G.H. Gibbons, K.E. Ellison, W. Lee, L. Zhang, H. Yu, Y. Kaneda, T. Ogihara, and V.J. Dzau. 1994. Evidence for direct local effect of angiotensin in vascular hypertrophy. In vivo gene transfer of angiotensin converting enzyme. J. Clin. Invest. 94:978-984.
30. Schiffrin, E.L., J.B. Park, H.D. Intengan, and R.M. Touyz. 2000. Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan. Circulation. 101:1653-1659.
31. Cai, H., K.K. Griendling, and D.G. Harrison. 2003. The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol. Sci. 24:471-478.
32. Galkina, E., A. Kadl, J. Sanders, D. Varughese, I.J. Sarembock, and K. Ley. 2006. Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially L-selectin dependent. J. Exp. Med. 203:1273-1282.
33. Liu, J., F. Yang, X.P. Yang, M. Jankowski, and P.J. Pagano. 2003. NAD(P)H Oxidase Mediates Angiotensin II-induced vascular macrophage infiltration and medial hypertrophy. Arterioscler. Thromb. Vasc. Biol. 23:776-782.
34. Somers, M.J., K. Mavromatis, Z.S. Galis, and D.G. Harrison. 2000. Vascular superoxide production and vasomotor function in hypertension induced by deoxycorticosterone acetate-salt. Circulation. 101:1722-1728.
35. Hayday, A., and R. Tigelaar. 2003. Immunoregulation in the tissues by gammadelta T cells. Nat. Rev. Immunol. 3:233-242.
36. Antonelli, L.R., W.O. Dutra, R.R. Oliveira, K.C. Torres, L.H. Guimaraes, O. Bacellar, and K.J. Gollob. 2006. Disparate immunoregulatory potentials for double-negative (CD4- CD8-) alpha beta and gamma delta T cells from human patients with cutaneous leishmaniasis. Infect. Immun. 74:6317-6323.
37. Umemura, M., T. Kawabe, K. Shudo, H. Kidoya, M. Fukui, M. Asano, Y. Iwakura, G. Matsuzaki, R. Imamura, and T. Suda. 2004. Involvement of IL-17 in Fas ligand-induced inflammation. Int. Immunol. 16:1099-1108.
38. Clozel, M., H. Kuhn, F. Hefti, and H.R. Baumgartner. 1991. Endothelial dysfunction and subendothelial monocyte macrophages in hypertension. Effect of angiotensin converting enzyme inhibition. Hypertension. 18:132-141.
39. Hinglais, N., D. Heudes, A. Nicoletti, C. Mandet, M. Laurent, J. Bariety, and J.B. Michel. 1994. Colocalization of myocardial fibrosis and inflammatory cells in rats. Lab. Invest. 70:286-294.
40. Agace, W.W. 2006. Tissue-tropic effector T cells: generation and targeting opportunities. Nat. Rev. Immunol. 6:682-692.
41. Agrewala, J.N., D.M. Brown, N.M. Lepak, D. Duso, G. Huston, and S.L. Swain. 2007. Unique ability of activated CD4+ T cells but not rested effectors to migrate to non-lymphoid sites in the absence of inflammation. J. Biol. Chem. 282:6106-6115.
42. Wu, H., S. Ghosh, X.D. Perrard, L. Feng, G.E. Garcia, J.L. Perrard, J.F. Sweeney, L.E. Peterson, L. Chan, C.W. Smith, and C.M. Ballantyne. 2007. T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity. Circulation. 115:1029-1038.
43. Tilg, H., and A.R. Moschen. 2006. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat. Rev. Immunol. 6:772-783.
44. Guzik, T.J., D. Mangalat, and R. Korbut. 2006. Adipocytokines - novel link between inflammation and vascular function? J. Physiol. Pharmacol. 57:505-528.
45. Moore, L.L., A.J. Visioni, M.M. Qureshi, M.L. Bradlee, R.C. Ellison, and R. D'Agostino. 2005. Weight loss in overweight adults and the long-term risk of hypertension: the Framingham study. Arch. Intern. Med. 165:1298-1303.
46. Cowley, A.W., Jr., T. Mori, D. Mattson, and A.P. Zou. 2003. Role of renal NO production in the regulation of medullary blood flow. Am. J. Physiol. Regul. Integr. Comp. Physiol. 284:R1355-R1369.
47. Dickhout, J.G., T. Mori, and A.W. Cowley Jr. 2002. Tubulovascular nitric oxide crosstalk: buffering of angiotensin II-induced medullary vasoconstriction. Circ. Res. 91:487-493.
48. Mori, T., and A.W. Cowley Jr. 2004. Renal oxidative stress in medullary thick ascending limbs produced by elevated NaCl and glucose. Hypertension. 43:341-346.
49. Kabelitz, D. 2007. Expression and function of Toll-like receptors in T lymphocytes. Curr. Opin. Immunol. 19:39-45.
50. Parks, B.W., A.J. Lusis, and J.H. Kabarowski. 2006. Loss of the ly sophosphatidylcholine effector, G2A, ameliorates aortic atherosclerosis in low-density lipoprotein receptor knockout mice. Arterioscler. Thromb. Vasc. Biol. 26:2703-2709.
51. De Keulenaer, G.W., R.W. Alexander, M. Ushio-Fukai, N. Ishizaka, and K.K. Griendling. 1998. Tumour necrosis factor alpha activates a p22phox-based NADH oxidase in vascular smooth muscle. Biochem. J. 329 (Pt 3):653-657.
52. Picchi, A., X. Gao, S. Belmadani, B.J. Potter, M. Focardi, W.M. Chilian, and C. Zhang. 2006. Tumor necrosis factor-alpha induces endothelial dysfunction in the prediabetic metabolic syndrome. Circ. Res. 99:69-77.
53. Gavras, H., H.R. Brunner, J.H. Laragh, E.D. Vaughan Jr., M. Koss, L.J. Cote, and I. Gavras. 1975. Malignant hypertension resulting from deoxycorticosterone acetate and salt excess: role of renin and sodium in vascular changes. Circ. Res. 36:300-309.
54. Parker, S.B., S.S. Wade, and R.L. Prewitt. 1998. Pressure mediates angiotensin II-induced arterial hypertrophy and PDGF-A expression. Hypertension. 32:452-458.
55. Huang, M., R.L. Hester, T.G. Coleman, M.J. Smith, and A.C. Guyton. 1992. Development of hypertension in animals with reduced total peripheral resistance. Hypertension. 20:828-833.
56. Guyton, A.C., A.W. Cowley Jr., D.B. Young, T.G. Coleman, J.E. Hall, and J.W. DeClue. 1976. Integration and control of circulatory function. Int. Rev. Physiol. 9:341-385.
57. McDonough, A.A., P.K. Leong, and L.E. Yang. 2003. Mechanisms of pressure natriuresis: how blood pressure regulates renal sodium transport. Ann. N. Y. Acad. Sci. 986:669-677.
58. Chapleau, M.W., G. Hajduczok, and F.M. Abboud. 1989. Peripheral and central mechanisms of baroreflex resetting. Clin. Exp. Pharmacol. Physiol. Suppl. 15:31-43.
59. Laude, K., H. Cai, B. Fink, N. Hoch, D.S. Weber, L. McCann, G. Kojda, T. Fukai, H.H. Schmidt, S. Dikalov, et al. 2005. Hemodynamic and biochemical adaptations to vascular smooth muscle overexpression of p22phox in mice. Am. J. Physiol. Heart Circ. Physiol. 288:H7-12.
60. Hehner, S.P., R. Breitkreutz, G. Shubinsky, H. Unsoeld, K. Schulze-Osthoff, M.L. Schmitz, and W. Droge. 2000. Enhancement of T cell receptor signaling by a mild oxidative shift in the intracellular thiol pool. J. Immunol. 165:4319-4328.
61. Elmarakby, A.A., J.E. Quigley, D.M. Pollock, and J.D. Imig. 2006. Tumor necrosis factor alpha blockade increases renal Cyp2c23 expression and slows the progression of renal damage in salt-sensitive hypertension. Hypertension. 47:557-562.
62. Maki-Petaja, K.M., F.C. Hall, A.D. Booth, S.M. Wallace, Yasmin, P.W. Bearcroft, S. Harish, A. Furlong, C.M. McEniery, J. Brown, and I.B. Wilkinson. 2006. Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factoralpha therapy. Circulation. 114:1185-1192.
63. Zimmerman, M.C., R.P. Dunlay, E. Lazartigues, Y. Zhang, R.V. Sharma, J.F. Engelhardt, and R.L. Davisson. 2004. Requirement for Rac1-dependent NADPH oxidase in the cardiovascular and dipsogenic actions of angiotensin II in the brain. Circ. Res. 95:532-539.
64. Felten, D.L., S. Livnat, S.Y. Felten, S.L. Carlson, D.L. Bellinger, and P. Yeh. 1984. Sympathetic innervation of lymph nodes in mice. Brain Res. Bull. 13:693-699.
65. Romano, T.A., S.Y. Felten, J.A. Olschowka, and D.L. Felten. 1994. Noradrenergic and peptidergic innervation of lymphoid organs in the beluga, Delphinapterus leucas: an anatomical link between the nervous and immune systems. J. Morphol. 221:243-259.
66. Madden, K.S., S.Y. Felten, D.L. Felten, C.A. Hardy, and S. Livnat. 1994. Sympathetic nervous system modulation of the immune system. II. Induction of lymphocyte proliferation and migration in vivo by chemical sympathectomy. J. Neuroimmunol. 49:67-75.
67. van der Veen, R.C., T.A. Dietlin, A. Karapetian, S.M. Holland, and F.M. Hofman. 2004. Extra-cellular superoxide promotes T cell expansion through inactivation of nitric oxide. J. Neuroimmunol. 153:183-189.
68. Rajagopalan, S., S. Kurz, T. Munzel, M. Tarpey, B.A. Freeman, K.K. Griendling, and D.G. Harrison. 1996. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J. Clin. Invest. 97:1916-1923.
69. Widder, J.D., T.J. Guzik, C.F. Mueller, R.E. Clempus, H.H. Schmidt, S.I. Dikalov, K.K. Griendling, D.P. Jones, and D.G. Harrison. 2007. Role of the multidrug resistance protein-1 in hypertension and vascular dysfunction caused by angiotensin II. Arterioscler Thromb Vasc Biol. 27:762-768.
70. Fink, B., K. Laude, L. McCann, A. Doughan, D.G. Harrison, and S. Dikalov. 2004. Detection of intracellular superoxide formation in endothelial cells and intact tissues using dihydroethidium and an HPLC-based assay. Am. J. Physiol. Cell Physiol. 287:C895-C902.
71. Gongora, M.C., Z. Qin, K. Laude, H.W. Kim, L. McCann, J.R. Folz, S. Dikalov, T. Fukai, and D.G. Harrison. 2006. Role of extracellular superoxide dismutase in hypertension. Hypertension. 48:473-478.